Carole A. Federico

Most-cited papers

1. Health utilities and psychometric quality of life in patients with early‐ and late‐stage hepatitis C virus infection

   Priscilla C. Hsu, Carole A. Federico, M. Krajden, Eric M. Yoshida +4 more

   2012Journal of Gastroenterology and Hepatology82 citations

   Semantic Scholar

   Save

2. Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment?

   S. Wieschowski, W. Chin, Carole A. Federico, Sören Sievers +2 more

   2018PLoS Biology68 citations Open access

   Semantic Scholar

   Save

3. Consider drug efficacy before first-in-human trials

   J. Kimmelman, Carole A. Federico

   2017Nature60 citations Open access

   Semantic Scholar

   Save

4. A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib

   Valerie C. Henderson, N. Demko, Amanda K. Hakala, Nathalie Mackinnon +3 more

   2015eLife39 citations Open access

   Semantic Scholar

   Save

5. Assessment of Pregabalin Postapproval Trials and the Suggestion of Efficacy for New Indications: A Systematic Review

   Carole A. Federico, Taiji Wang, A. Doussau, J. Mogil +2 more

   2019JAMA Internal Medicine28 citations

   Semantic Scholar

   Save

6. Patient time costs and out‐of‐pocket costs in hepatitis C

   Carole A. Federico, Priscilla C. Hsu, M. Krajden, Eric M. Yoshida +4 more

   2012Liver international (Print)25 citations

   Semantic Scholar

   Save

7. Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross‐sectional study

   Holger Langhof, W. Chin, S. Wieschowski, Carole A. Federico +2 more

   2018British Journal of Pharmacology24 citations Open access

   Semantic Scholar

   Save

8. A systematic review and meta-analysis of pregabalin preclinical studies.

   Carole A. Federico, J. Mogil, T. Ramsay, D. Fergusson +1 more

   2020Pain19 citations

   Semantic Scholar

   Save

9. Trials that say “maybe”: the disconnect between exploratory and confirmatory testing after drug approval

   B. Carlisle, Carole A. Federico, J. Kimmelman

   2018British medical journal16 citations Open access

   Semantic Scholar

   Save

10. Late, never or non‐existent: the inaccessibility of preclinical evidence for new drugs

    Carole A. Federico, B. Carlisle, Jonathan Kimmelman, Dean A. Fergusson

    2014British Journal of Pharmacology9 citations Open access

    Semantic Scholar

    Save

11. Response to Moisset et al.

    Carole A. Federico, J. Mogil, T. Ramsay, D. Fergusson +1 more

    2020Pain0 citations

    Semantic Scholar

    Save

12. Efficacy of spinal cord stimulation : uncertain at best Letter to

    Carole A. Federico, J. Mogil, T. Ramsay, D. Fergusson +1 more

    20200 citations

    Semantic Scholar

    Save

13. Author response: A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib

    Valerie C. Henderson, N. Demko, Amanda K. Hakala, Nathalie Mackinnon +3 more

    20150 citations Open access

    Semantic Scholar

    Save